Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V A Tron

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Cutaneous Pathology|August 1, 1991
Analysis of HMB-45 immunoreactivity in common and cellular blue neviW S Wood, V A Tron
The Journal of Pathology|August 1, 1994
Dermal vascularity in lentigo malignaM J Trotter, V A Tron
Journal of Cutaneous Medicine and Surgery|March 22, 2002
Ultraviolet light (UV) regulation of the TNF family decoy receptors DcR2 and DcR3 in human keratinocytesT Maeda, C Hao, V A Tron
Journal of Cutaneous Medicine and Surgery|November 26, 2002
Thrombospondin-1 and cutaneous melanomaM J Trotter, R Colwell, V A Tron
Journal of Cutaneous Pathology|February 4, 1998
The Xiphophorus-derived antibody, XMEL, shows sensitivity and specificity for human cutaneous melanoma but is not a prognostic markerJ R Vielkind, K Huhn, V A Tron
Human Pathology|May 1, 1995
Site-specific comparison of p53 immunostaining in squamous cell carcinomasL K Coulter, R Wolber, V A Tron
Melanoma Research|June 1, 1997
The melanoma-specific XMEL antigen is expressed in dysplastic naeviV A Tron, R Crawford, J R Vielkind
Journal of Cutaneous Pathology|May 1, 1997
Overexpression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in human cutaneous malignant melanomaM J Trotter, L Tang, V A Tron
The Journal of Investigative Dermatology|March 1, 1988
Epidermal interleukin-1 is increased in cutaneous T-cell lymphomaV A Tron, D Rosenthal, D N Sauder
Human Pathology|December 1, 1990
Malignant melanoma in situ: functional considerations of cancerV A Tron, R L Barnhill, M C Mihm
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Cutaneous Pathology|August 1, 1991
Analysis of HMB-45 immunoreactivity in common and cellular blue neviW S Wood, V A Tron
The Journal of Pathology|August 1, 1994
Dermal vascularity in lentigo malignaM J Trotter, V A Tron
Journal of Cutaneous Medicine and Surgery|March 22, 2002
Ultraviolet light (UV) regulation of the TNF family decoy receptors DcR2 and DcR3 in human keratinocytesT Maeda, C Hao, V A Tron
Journal of Cutaneous Medicine and Surgery|November 26, 2002
Thrombospondin-1 and cutaneous melanomaM J Trotter, R Colwell, V A Tron
Journal of Cutaneous Pathology|February 4, 1998
The Xiphophorus-derived antibody, XMEL, shows sensitivity and specificity for human cutaneous melanoma but is not a prognostic markerJ R Vielkind, K Huhn, V A Tron
Human Pathology|May 1, 1995
Site-specific comparison of p53 immunostaining in squamous cell carcinomasL K Coulter, R Wolber, V A Tron
Melanoma Research|June 1, 1997
The melanoma-specific XMEL antigen is expressed in dysplastic naeviV A Tron, R Crawford, J R Vielkind
Journal of Cutaneous Pathology|May 1, 1997
Overexpression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in human cutaneous malignant melanomaM J Trotter, L Tang, V A Tron
The Journal of Investigative Dermatology|March 1, 1988
Epidermal interleukin-1 is increased in cutaneous T-cell lymphomaV A Tron, D Rosenthal, D N Sauder
Human Pathology|December 1, 1990
Malignant melanoma in situ: functional considerations of cancerV A Tron, R L Barnhill, M C Mihm
Pageof 5